The data showed that roughly 65% of the cells in the oxygenated devices remained viable compared to roughly 20% in control devices.

Many organizations still lack structured media optimization and alignment between development and manufacturing, according to Lonza.

The data shows that inhibiting TIE2 with rebastinib could prevent new abnormalities from forming in the brain with fewer side effects.

GEN Live panelists will explore how stem cells are transforming disease modeling, drug discovery, and personalized medicine with perspectives on clinical trial progress and hurdles such as ...

Beyond resistance‑associated genes, the researchers uncovered deep geographic population structure and high overall genetic diversity.

Study findings indicate that environmentally relevant doses of OLA bioplastics may be “more toxic” to the placenta than ...

The connection between cancer response and autoimmune disease in the brain lies with the antibodies deployed to fight cancer.

UCB has achieved 15 FDA approvals or indication expansions, nine of which were secured in the past three years.

It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the buyer’s cancer pipeline with that of Terns—led by an oral tyrosine kinase ...

Realizing the benefits of regenerative medicine will require a structural shift toward earlier detection and therapeutic intervention.

The newest production line at the Milford site represents the largest expansion in Rentschler Biopharma’s more than 150-year history.